These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12182467)

  • 1. Remission and pancreas isograft survival in recent onset diabetic NOD mice after treatment with low-dose anti-CD3 monoclonal antibodies.
    Mottram PL; Murray-Segal LJ; Han W; Maguire J; Stein-Oakley AN
    Transpl Immunol; 2002 Jun; 10(1):63-72. PubMed ID: 12182467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival of segmental pancreas isografts in NOD/Lt mice treated with anti-CD4 and anti-CD8 monoclonal antibodies.
    Mottram PL; Murray-Segal LJ; Han W; Maguire J; Stein-Oakley A; Mandel TE
    Diabetes; 1998 Sep; 47(9):1399-405. PubMed ID: 9726227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.
    Drage M; Zaccone P; Phillips JM; Nicoletti F; Dawson J; Andrew Bradley J; Cooke A
    Transplantation; 2002 Sep; 74(5):611-9. PubMed ID: 12352875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.
    Chatenoud L; Thervet E; Primo J; Bach JF
    Proc Natl Acad Sci U S A; 1994 Jan; 91(1):123-7. PubMed ID: 8278351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines and autoimmune beta cell destruction in NOD mouse fetal pancreas isografts in cyclophosphamide-induced diabetes.
    Kovarik J; Faulkner-Jones BE; Koulmanda M; Mandel TE
    Autoimmunity; 1997; 26(4):245-52. PubMed ID: 9543185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.
    Makhlouf L; Grey ST; Dong V; Csizmadia E; Arvelo MB; Auchincloss H; Ferran C; Sayegh MH
    Transplantation; 2004 Apr; 77(7):990-7. PubMed ID: 15087759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial and transient modulation of the CD3-T-cell receptor complex, elicited by low-dose regimens of monoclonal anti-CD3, is sufficient to induce disease remission in non-obese diabetic mice.
    Mehta DS; Christmas RA; Waldmann H; Rosenzweig M
    Immunology; 2010 May; 130(1):103-13. PubMed ID: 20059577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission of type 1 diabetes after anti-CD3 antibody treatment and transplantation of embryonic pancreatic precursors.
    Begum S; Chen W; Herold KC; Papaioannou VE
    Endocrinology; 2009 Oct; 150(10):4512-20. PubMed ID: 19589867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum.
    Maki T; Ichikawa T; Blanco R; Porter J
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3434-8. PubMed ID: 1565635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD3 monoclonal antibodies: a first step towards operational immune tolerance in the clinic.
    Chatenoud L; Waldmann H
    Rev Diabet Stud; 2012; 9(4):372-81. PubMed ID: 23804274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
    Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
    Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low doses of anti-CD3, ciclosporin A and the vitamin D analogue, TX527, synergise to delay recurrence of autoimmune diabetes in an islet-transplanted NOD mouse model of diabetes.
    Baeke F; Van Belle TL; Takiishi T; Ding L; Korf H; Laureys J; Gysemans C; Mathieu C
    Diabetologia; 2012 Oct; 55(10):2723-2732. PubMed ID: 22752077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.
    Christianson SW; Shultz LD; Leiter EH
    Diabetes; 1993 Jan; 42(1):44-55. PubMed ID: 8093606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral histone deacetylase inhibitor synergises with T cell targeted immunotherapy to preserve beta cell metabolic function and induce stable remission of new-onset autoimmune diabetes in NOD mice.
    Besançon A; Goncalves T; Valette F; Dahllöf MS; Mandrup-Poulsen T; Chatenoud L; You S
    Diabetologia; 2018 Feb; 61(2):389-398. PubMed ID: 29030662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells.
    Sherry NA; Chen W; Kushner JA; Glandt M; Tang Q; Tsai S; Santamaria P; Bluestone JA; Brillantes AM; Herold KC
    Endocrinology; 2007 Nov; 148(11):5136-44. PubMed ID: 17673522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
    Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M
    Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal pancreas transplantation in non-obese diabetic (NOD) mice. A comparison of iso-, allo- and xenografts.
    Mandel TE; Koulmanda M; Bacelj A
    Horm Metab Res Suppl; 1990; 25():166-73. PubMed ID: 2088961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunohistochemical study of macrophage influx and the co-localization of inducible nitric oxide synthase in the pancreas of non-obese diabetic (NOD) mice during disease acceleration with cyclophosphamide.
    Reddy S; Yip S; Karanam M; Poole CA; Ross JM
    Histochem J; 1999 May; 31(5):303-14. PubMed ID: 10461865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic reversal of type 1 diabetes in NOD mice with anti-CD3 and interleukin-1 blockade: evidence of improved immune regulation.
    Ablamunits V; Henegariu O; Hansen JB; Opare-Addo L; Preston-Hurlburt P; Santamaria P; Mandrup-Poulsen T; Herold KC
    Diabetes; 2012 Jan; 61(1):145-54. PubMed ID: 22043003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal relationship between immune cell influx and the expression of inducible nitric oxide synthase, interleukin-4 and interferon-gamma in pancreatic islets of NOD mice following adoptive transfer of diabetic spleen cells.
    Reddy S; Karanam M; Krissansen G; Nitschke K; Neve J; Poole CA; Ross JM
    Histochem J; 2000 Apr; 32(4):195-206. PubMed ID: 10872884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.